Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer

Analysis of circulating DNA derived from cancer cells, which is frequently known as a "liquid biopsy," is being evaluated as a tool in the care of patients with cancer. Although a wide range of cancer-associated changes, including point mutations, copy-number aberrations, and alterations in DNA…

http://ift.tt/2vRuFbm